Article
Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow.
Haematologica - 1 Jun 2018
Bansal Dhruv, Vij Kiran, Chang Gue Su, Miller Christopher A, DiPersio John F, Vij Ravi, Heath Sharon E, Westervelt Peter, Welch John S, Fehniger Todd A
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.